Dasatinib and Dexamethasone Combination Therapy Targets Myeloma and the Tumor Microenvironment

被引：0
|
作者：
Ramasamy, K. A. [1 ]
Macpherson, L. [1 ]
Mufti, G. [1 ]
Schey, S. [1 ]
Calle, Y. [1 ]
机构：
[1] Kings Coll London, London, England
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
D O I：
10.1016/S1557-9190(11)70692-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S116 / S117
页数：2
相关论文
共 50 条
  • [41] COMBINATION THERAPY WITH INTERFERON-DEXAMETHASONE FOR NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA
    DIMOPOULOS, MA
    WEBER, D
    DELASALLE, KB
    ALEXANIAN, R
    CANCER, 1993, 72 (09) : 2589 - 2592
  • [42] Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease
    Ramasamy, Karthik
    Hazel, Beth
    Mahmood, Shameem
    Corderoy, Sophie
    Schey, Stephen
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (05) : 632 - 634
  • [43] VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma
    M Pineda-Roman
    M Zangari
    F van Rhee
    E Anaissie
    J Szymonifka
    A Hoering
    N Petty
    J Crowley
    J Shaughnessy
    J Epstein
    B Barlogie
    Leukemia, 2008, 22 : 1419 - 1427
  • [44] Combination therapy with velcade, doxil, and dexamethasone (VDD) for patients with relapsed/refractory multiple myeloma (MM).
    Jakubowiak, AJ
    Brackett, L
    Kendall, T
    Friedman, J
    Kaminski, MS
    BLOOD, 2005, 106 (11) : 378B - 378B
  • [45] Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant
    Mangiacavalli, Silvia
    Pochintesta, Lara
    Ravelli, Erika
    Baldini, Luca
    Ferretti, Virginia Valeria
    La Targia, Maria Luisa
    Farina, Lucia
    Cocito, Federica
    Cairoli, Roberto
    Montefusco, Vittorio
    Corso, Alessandro
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1901 - 1902
  • [46] Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma
    Mangiameli, David P.
    Blansfield, Joseph A.
    Kachala, Stephan
    Lorang, Dominique
    Schafer, Peter H.
    Muller, George W.
    Stirling, David I.
    Libutti, Steven K.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5 (1)
  • [47] Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy
    Ding, Yue
    Wang, Chenwei
    Ma, Yuxuan
    Zhu, Lvming
    Lu, Bing
    Wang, Yang
    Wang, Jin
    Dong, Chang -Ming
    Yao, Yong
    ACTA BIOMATERIALIA, 2022, 146 : 396 - 405
  • [48] Transcriptomic rationale for the synergy observed with dasatinib plus bortezomib plus dexamethasone in multiple myeloma
    de Queiroz Crusoe, Edvan
    Maiso, Patricia
    Fernandez-Lazaro, Diego
    San-Segundo, Laura
    Garayoa, Mercedes
    Garcia-Gomez, Antonio
    Gutierrez, Norma C.
    Delgado, Manuel
    Colado, Enrique
    Martin-Sanchez, Jesus
    Lee, Francis Y.
    Ocio, Enrique M.
    ANNALS OF HEMATOLOGY, 2012, 91 (02) : 257 - 269
  • [49] Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
    Uckun, Fatih M.
    CANCERS, 2021, 13 (09)
  • [50] THE COMBINATION OF SUNITINIB AND KETOCONAZOLE TARGETED AT THE TUMOR MICROENVIRONMENT IMPROVES THE EFFICACY OF ANTICANCER THERAPY
    Kim, Hokyoung
    Pincus, Josh
    Greenberg, Jacob
    Raines, Amanda
    Abdel-Mageed, Asim
    Krane, Louis
    JOURNAL OF UROLOGY, 2020, 203 : E1305 - E1305
12345